HEADER HYDROLASE/INHIBITOR 03-MAR-25 9NLO TITLE ESCHERICHIA COLI SIGNAL PEPTIDASE I DELTA 2-76 P84A IN COMPLEX WITH TITLE 2 LIPOPEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SIGNAL PEPTIDASE I; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SPASE I,LEADER PEPTIDASE I; COMPND 5 EC: 3.4.21.89; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ARYLOMYCIN A2; COMPND 10 CHAIN: C, D; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K-12; SOURCE 5 ATCC: 27325; SOURCE 6 GENE: LEPB, B2568, JW2552; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET3D; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 13 ORGANISM_TAXID: 32630 KEYWDS SIGNAL PEPTIDASE, MEMBRANE PROTEIN, SERINE-LYSINE CATALYTIC DYAD, KEYWDS 2 INHIBITOR COMPLEX, HYDROLASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.PAETZEL,C.LUO REVDAT 2 26-NOV-25 9NLO 1 JRNL REVDAT 1 19-NOV-25 9NLO 0 JRNL AUTH C.LUO,M.PAETZEL JRNL TITL CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL JRNL TITL 2 PEPTIDASE P84A IN COMPLEX WITH LIPOPEPTIDE ANTIBIOTIC JRNL TITL 3 ARYLOMYCIN A 2 . JRNL REF J.STRUCT.BIOL. V. 217 08260 2025 JRNL REFN ESSN 1095-8657 JRNL PMID 41207487 JRNL DOI 10.1016/J.JSB.2025.108260 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.PAETZEL,J.J.GOODALL,M.KANIA,R.E.DALBEY,M.G.PAGE REMARK 1 TITL CRYSTALLOGRAPHIC AND BIOPHYSICAL ANALYSIS OF A BACTERIAL REMARK 1 TITL 2 SIGNAL PEPTIDASE IN COMPLEX WITH A LIPOPEPTIDE-BASED REMARK 1 TITL 3 INHIBITOR. REMARK 1 REF J BIOL CHEM V. 279 30781 2004 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 15136583 REMARK 1 DOI 10.1074/JBC.M401686200 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.LUO,P.ROUSSEL,J.DREIER,M.G.PAGE,M.PAETZEL REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF BACTERIAL SIGNAL PEPTIDASE IN REMARK 1 TITL 2 TERNARY COMPLEX WITH ARYLOMYCIN A2 AND A BETA-SULTAM REMARK 1 TITL 3 INHIBITOR. REMARK 1 REF BIOCHEMISTRY V. 48 8976 2009 REMARK 1 REFN ISSN 1520-4995 REMARK 1 PMID 19655811 REMARK 1 DOI 10.1021/BI9009538 REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0430 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 30716 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.643 REMARK 3 FREE R VALUE TEST SET COUNT : 1119 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.32 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2107 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.36 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3570 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 124 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.54500 REMARK 3 B22 (A**2) : 0.54500 REMARK 3 B33 (A**2) : -1.09100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.247 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.195 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.326 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3692 ; 0.006 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 3387 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5015 ; 1.400 ; 1.849 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7793 ; 0.475 ; 1.784 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 448 ; 7.245 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 21 ;10.448 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 526 ;12.490 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 532 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4346 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 840 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 516 ; 0.185 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 48 ; 0.139 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1751 ; 0.179 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 155 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1811 ; 3.606 ; 4.520 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1811 ; 3.603 ; 4.520 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2252 ; 5.511 ; 8.091 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2253 ; 5.509 ; 8.091 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1881 ; 3.786 ; 4.789 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1882 ; 3.785 ; 4.790 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2763 ; 5.939 ; 8.687 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2764 ; 5.938 ; 8.687 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 9NLO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAR-25. REMARK 100 THE DEPOSITION ID IS D_1000293210. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1047 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30863 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 52.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.39200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25%V/V PEG 4000, 0.05M NH4OAC, 0.1M REMARK 280 NAOAC PH 4.6, 0.033M L-PROLINE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 131.65500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.90000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.90000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 197.48250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.90000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.90000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.82750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.90000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.90000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 197.48250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.90000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.90000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 65.82750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 131.65500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ARYLOMYCIN A2 IS A CYCLIC LIPOHEXAPEPTIDE, A MEMBER OF THE REMARK 400 ARYLOMYCIN FAMILY. ALL MEMBERS HAVE A FATTY ACID AT THE N-TERM AND REMARK 400 A CORE STRUCTURE OF TRIPEPTIDE MACROCYCLE FORMED BY A C-C BIARYL REMARK 400 LINKAGE BETWEEN RESIDUES 4 AND 6. HERE, ARYLOMYCIN A2 IS REMARK 400 REPRESENTED BY GROUPING TOGETHER THE SEQUENCE (SEQRES) AND ONE REMARK 400 LIGAND (HET) M12. REMARK 400 REMARK 400 THE ARYLOMYCIN A2 IS LIPOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ARYLOMYCIN A2 REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE M12 REMARK 400 DESCRIPTION: ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE REMARK 400 SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC REMARK 400 TRIPEPTIDE (2) A TRICYCLIC PEPTIDE, WITH [3,3] REMARK 400 BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY REMARK 400 ACID IS LINKED TO RESIDUE 1. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 76 REMARK 465 VAL A 77 REMARK 465 ARG A 78 REMARK 465 SER A 79 REMARK 465 GLN A 117 REMARK 465 LYS A 118 REMARK 465 THR A 119 REMARK 465 LEU A 120 REMARK 465 SER A 172 REMARK 465 SER A 173 REMARK 465 GLY A 174 REMARK 465 GLN A 175 REMARK 465 ALA A 176 REMARK 465 CYS A 177 REMARK 465 GLU A 178 REMARK 465 SER A 198 REMARK 465 ARG A 199 REMARK 465 ARG A 200 REMARK 465 ASN A 201 REMARK 465 GLY A 202 REMARK 465 GLY A 203 REMARK 465 GLU A 204 REMARK 465 ALA A 205 REMARK 465 MET B 76 REMARK 465 VAL B 77 REMARK 465 ILE B 111 REMARK 465 LYS B 112 REMARK 465 ASP B 113 REMARK 465 PRO B 114 REMARK 465 ILE B 115 REMARK 465 TYR B 116 REMARK 465 GLN B 117 REMARK 465 LYS B 118 REMARK 465 THR B 119 REMARK 465 LEU B 120 REMARK 465 SER B 172 REMARK 465 SER B 173 REMARK 465 GLY B 174 REMARK 465 GLN B 175 REMARK 465 ALA B 176 REMARK 465 CYS B 177 REMARK 465 GLU B 178 REMARK 465 ASN B 179 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 80 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE A 111 CG1 CG2 CD1 REMARK 470 LYS A 112 CG CD CE NZ REMARK 470 ILE A 115 CG1 CG2 CD1 REMARK 470 TYR A 116 O CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 116 OH REMARK 470 ILE A 121 N CG1 CG2 CD1 REMARK 470 GLU A 122 CG CD OE1 OE2 REMARK 470 THR A 123 OG1 CG2 REMARK 470 LYS A 127 CE NZ REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 LYS A 141 CD CE NZ REMARK 470 LYS A 155 NZ REMARK 470 CYS A 171 SG REMARK 470 ASN A 179 CG OD1 ND2 REMARK 470 GLU A 189 CD OE1 OE2 REMARK 470 PHE A 197 CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR A 206 CG2 REMARK 470 GLU A 219 CG CD OE1 OE2 REMARK 470 GLU A 310 CG CD OE1 OE2 REMARK 470 TRP A 311 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 311 CZ3 CH2 REMARK 470 THR A 313 OG1 CG2 REMARK 470 ARG B 78 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 81 CD1 REMARK 470 ILE B 121 CG1 CG2 CD1 REMARK 470 GLU B 122 CG CD OE1 OE2 REMARK 470 THR B 123 OG1 REMARK 470 LYS B 155 CE NZ REMARK 470 GLN B 168 OE1 NE2 REMARK 470 CYS B 171 SG REMARK 470 ARG B 200 NE CZ NH1 NH2 REMARK 470 GLU B 204 CG CD OE1 OE2 REMARK 470 GLU B 219 CG CD OE1 OE2 REMARK 470 ASP B 233 CG OD1 OD2 REMARK 470 MET B 250 CG SD CE REMARK 470 GLN B 258 CG CD OE1 NE2 REMARK 470 ILE B 263 CD1 REMARK 470 GLU B 310 CG CD OE1 OE2 REMARK 470 TRP B 311 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 311 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR C 6 CG TYR C 6 CD2 0.122 REMARK 500 TYR C 6 CD1 TYR C 6 CE1 0.138 REMARK 500 TYR C 6 CZ TYR C 6 CE2 0.142 REMARK 500 TYR D 6 CG TYR D 6 CD2 0.118 REMARK 500 TYR D 6 CD1 TYR D 6 CE1 0.142 REMARK 500 TYR D 6 CZ TYR D 6 CE2 0.136 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 140 1.30 -59.97 REMARK 500 VAL A 294 -64.71 -105.12 REMARK 500 ARG A 316 76.20 -112.58 REMARK 500 ALA B 260 14.91 81.63 REMARK 500 ASP B 281 -159.47 -137.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 275 ARG B 276 -148.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 276 0.19 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 M12 C 101 REMARK 610 M12 D 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B12 RELATED DB: PDB REMARK 900 BETA-LACTAM INHIBITOR REMARK 900 RELATED ID: 1KN9 RELATED DB: PDB REMARK 900 FREE ACTIVE SITE REMARK 900 RELATED ID: 1T7D RELATED DB: PDB REMARK 900 WILD TYPE ENZYME WITH LIPOPEPTIDE INHIBITOR REMARK 900 RELATED ID: 3IIQ RELATED DB: PDB REMARK 900 ARYLOMYCIN A2 AND A BETA-SULTAM INHIBITOR REMARK 900 RELATED ID: 3S04 RELATED DB: PDB REMARK 900 AN ARYLOMYCIN LIPOGLYCOPEPTIDE ANTIBIOTIC DBREF 9NLO A 77 324 UNP P00803 LEP_ECOLI 77 324 DBREF 9NLO B 77 324 UNP P00803 LEP_ECOLI 77 324 DBREF 9NLO C 1 6 PDB 9NLO 9NLO 1 6 DBREF 9NLO D 1 6 PDB 9NLO 9NLO 1 6 SEQADV 9NLO MET A 76 UNP P00803 INITIATING METHIONINE SEQADV 9NLO ALA A 84 UNP P00803 PRO 84 ENGINEERED MUTATION SEQADV 9NLO MET B 76 UNP P00803 INITIATING METHIONINE SEQADV 9NLO ALA B 84 UNP P00803 PRO 84 ENGINEERED MUTATION SEQRES 1 A 249 MET VAL ARG SER PHE ILE TYR GLU ALA PHE GLN ILE PRO SEQRES 2 A 249 SER GLY SER MET MET PRO THR LEU LEU ILE GLY ASP PHE SEQRES 3 A 249 ILE LEU VAL GLU LYS PHE ALA TYR GLY ILE LYS ASP PRO SEQRES 4 A 249 ILE TYR GLN LYS THR LEU ILE GLU THR GLY HIS PRO LYS SEQRES 5 A 249 ARG GLY ASP ILE VAL VAL PHE LYS TYR PRO GLU ASP PRO SEQRES 6 A 249 LYS LEU ASP TYR ILE LYS ARG ALA VAL GLY LEU PRO GLY SEQRES 7 A 249 ASP LYS VAL THR TYR ASP PRO VAL SER LYS GLU LEU THR SEQRES 8 A 249 ILE GLN PRO GLY CYS SER SER GLY GLN ALA CYS GLU ASN SEQRES 9 A 249 ALA LEU PRO VAL THR TYR SER ASN VAL GLU PRO SER ASP SEQRES 10 A 249 PHE VAL GLN THR PHE SER ARG ARG ASN GLY GLY GLU ALA SEQRES 11 A 249 THR SER GLY PHE PHE GLU VAL PRO LYS ASN GLU THR LYS SEQRES 12 A 249 GLU ASN GLY ILE ARG LEU SER GLU ARG LYS GLU THR LEU SEQRES 13 A 249 GLY ASP VAL THR HIS ARG ILE LEU THR VAL PRO ILE ALA SEQRES 14 A 249 GLN ASP GLN VAL GLY MET TYR TYR GLN GLN PRO GLY GLN SEQRES 15 A 249 GLN LEU ALA THR TRP ILE VAL PRO PRO GLY GLN TYR PHE SEQRES 16 A 249 MET MET GLY ASP ASN ARG ASP ASN SER ALA ASP SER ARG SEQRES 17 A 249 TYR TRP GLY PHE VAL PRO GLU ALA ASN LEU VAL GLY ARG SEQRES 18 A 249 ALA THR ALA ILE TRP MET SER PHE ASP LYS GLN GLU GLY SEQRES 19 A 249 GLU TRP PRO THR GLY LEU ARG LEU SER ARG ILE GLY GLY SEQRES 20 A 249 ILE HIS SEQRES 1 B 249 MET VAL ARG SER PHE ILE TYR GLU ALA PHE GLN ILE PRO SEQRES 2 B 249 SER GLY SER MET MET PRO THR LEU LEU ILE GLY ASP PHE SEQRES 3 B 249 ILE LEU VAL GLU LYS PHE ALA TYR GLY ILE LYS ASP PRO SEQRES 4 B 249 ILE TYR GLN LYS THR LEU ILE GLU THR GLY HIS PRO LYS SEQRES 5 B 249 ARG GLY ASP ILE VAL VAL PHE LYS TYR PRO GLU ASP PRO SEQRES 6 B 249 LYS LEU ASP TYR ILE LYS ARG ALA VAL GLY LEU PRO GLY SEQRES 7 B 249 ASP LYS VAL THR TYR ASP PRO VAL SER LYS GLU LEU THR SEQRES 8 B 249 ILE GLN PRO GLY CYS SER SER GLY GLN ALA CYS GLU ASN SEQRES 9 B 249 ALA LEU PRO VAL THR TYR SER ASN VAL GLU PRO SER ASP SEQRES 10 B 249 PHE VAL GLN THR PHE SER ARG ARG ASN GLY GLY GLU ALA SEQRES 11 B 249 THR SER GLY PHE PHE GLU VAL PRO LYS ASN GLU THR LYS SEQRES 12 B 249 GLU ASN GLY ILE ARG LEU SER GLU ARG LYS GLU THR LEU SEQRES 13 B 249 GLY ASP VAL THR HIS ARG ILE LEU THR VAL PRO ILE ALA SEQRES 14 B 249 GLN ASP GLN VAL GLY MET TYR TYR GLN GLN PRO GLY GLN SEQRES 15 B 249 GLN LEU ALA THR TRP ILE VAL PRO PRO GLY GLN TYR PHE SEQRES 16 B 249 MET MET GLY ASP ASN ARG ASP ASN SER ALA ASP SER ARG SEQRES 17 B 249 TYR TRP GLY PHE VAL PRO GLU ALA ASN LEU VAL GLY ARG SEQRES 18 B 249 ALA THR ALA ILE TRP MET SER PHE ASP LYS GLN GLU GLY SEQRES 19 B 249 GLU TRP PRO THR GLY LEU ARG LEU SER ARG ILE GLY GLY SEQRES 20 B 249 ILE HIS SEQRES 1 C 6 DSE DAL GLY 5PG ALA TYR SEQRES 1 D 6 DSE DAL GLY 5PG ALA TYR HET DSE C 1 7 HET DAL C 2 5 HET 5PG C 4 12 HET DSE D 1 7 HET DAL D 2 5 HET 5PG D 4 12 HET EDO A 401 4 HET EDO B 401 4 HET M12 C 101 12 HET M12 D 101 12 HETNAM DSE N-METHYL-D-SERINE HETNAM DAL D-ALANINE HETNAM 5PG (2S)-(4-HYDROXYPHENYL)(METHYLAMINO)ETHANOIC ACID HETNAM EDO 1,2-ETHANEDIOL HETNAM M12 10-METHYLUNDECANOIC ACID HETSYN 5PG N-METHYL-4-HYDROXY-PHENYLGLYCINE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 DSE 2(C4 H9 N O3) FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 5PG 2(C9 H11 N O3) FORMUL 5 EDO 2(C2 H6 O2) FORMUL 7 M12 2(C12 H24 O2) FORMUL 9 HOH *124(H2 O) HELIX 1 AA1 GLN A 247 TYR A 251 5 5 HELIX 2 AA2 ASP A 281 GLY A 286 1 6 HELIX 3 AA3 LEU A 317 ILE A 320 5 4 HELIX 4 AA4 GLN B 247 TYR B 251 5 5 HELIX 5 AA5 ASP B 281 GLY B 286 1 6 HELIX 6 AA6 LEU B 317 ILE B 320 5 4 SHEET 1 AA1 6 VAL A 288 PRO A 289 0 SHEET 2 AA1 6 GLN A 268 MET A 272 -1 N TYR A 269 O VAL A 288 SHEET 3 AA1 6 ASP A 143 GLY A 150 -1 N ARG A 147 O MET A 272 SHEET 4 AA1 6 ILE A 131 LYS A 135 -1 N PHE A 134 O TYR A 144 SHEET 5 AA1 6 LEU A 293 ASP A 305 -1 O VAL A 294 N VAL A 133 SHEET 6 AA1 6 GLY A 314 LEU A 315 -1 O GLY A 314 N ASP A 305 SHEET 1 AA2 8 VAL A 288 PRO A 289 0 SHEET 2 AA2 8 GLN A 268 MET A 272 -1 N TYR A 269 O VAL A 288 SHEET 3 AA2 8 ASP A 143 GLY A 150 -1 N ARG A 147 O MET A 272 SHEET 4 AA2 8 ILE A 131 LYS A 135 -1 N PHE A 134 O TYR A 144 SHEET 5 AA2 8 LEU A 293 ASP A 305 -1 O VAL A 294 N VAL A 133 SHEET 6 AA2 8 ASP A 100 LYS A 106 -1 N PHE A 101 O MET A 302 SHEET 7 AA2 8 TYR A 82 GLN A 86 -1 N GLU A 83 O VAL A 104 SHEET 8 AA2 8 GLY D 3 5PG D 4 1 O GLY D 3 N GLN A 86 SHEET 1 AA3 3 GLU A 164 GLN A 168 0 SHEET 2 AA3 3 LYS A 155 ASP A 159 -1 N THR A 157 O THR A 166 SHEET 3 AA3 3 THR A 261 ILE A 263 -1 O TRP A 262 N VAL A 156 SHEET 1 AA4 4 VAL A 183 TYR A 185 0 SHEET 2 AA4 4 ILE A 222 LEU A 231 -1 O THR A 230 N THR A 184 SHEET 3 AA4 4 GLU A 189 GLN A 195 -1 N GLU A 189 O GLU A 226 SHEET 4 AA4 4 PHE A 209 GLU A 211 -1 O PHE A 210 N VAL A 194 SHEET 1 AA5 3 VAL A 183 TYR A 185 0 SHEET 2 AA5 3 ILE A 222 LEU A 231 -1 O THR A 230 N THR A 184 SHEET 3 AA5 3 VAL A 234 THR A 240 -1 O HIS A 236 N GLU A 229 SHEET 1 AA6 4 GLU B 122 THR B 123 0 SHEET 2 AA6 4 ASP B 100 TYR B 109 -1 N TYR B 109 O GLU B 122 SHEET 3 AA6 4 LEU B 293 ASP B 305 -1 O MET B 302 N PHE B 101 SHEET 4 AA6 4 GLY B 314 LEU B 315 -1 O GLY B 314 N ASP B 305 SHEET 1 AA7 8 VAL B 288 PRO B 289 0 SHEET 2 AA7 8 GLN B 268 MET B 272 -1 N TYR B 269 O VAL B 288 SHEET 3 AA7 8 ASP B 143 GLY B 150 -1 N ARG B 147 O MET B 272 SHEET 4 AA7 8 ILE B 131 LYS B 135 -1 N PHE B 134 O TYR B 144 SHEET 5 AA7 8 LEU B 293 ASP B 305 -1 O VAL B 294 N VAL B 133 SHEET 6 AA7 8 ASP B 100 TYR B 109 -1 N PHE B 101 O MET B 302 SHEET 7 AA7 8 PHE B 80 GLN B 86 -1 N GLU B 83 O VAL B 104 SHEET 8 AA7 8 GLY C 3 5PG C 4 1 O GLY C 3 N GLN B 86 SHEET 1 AA8 3 GLU B 164 GLN B 168 0 SHEET 2 AA8 3 LYS B 155 ASP B 159 -1 N LYS B 155 O GLN B 168 SHEET 3 AA8 3 THR B 261 ILE B 263 -1 O TRP B 262 N VAL B 156 SHEET 1 AA9 4 VAL B 183 TYR B 185 0 SHEET 2 AA9 4 ILE B 222 LEU B 231 -1 O THR B 230 N THR B 184 SHEET 3 AA9 4 GLU B 189 ARG B 199 -1 N GLU B 189 O GLU B 226 SHEET 4 AA9 4 ALA B 205 GLU B 211 -1 O GLY B 208 N THR B 196 SHEET 1 AB1 3 VAL B 183 TYR B 185 0 SHEET 2 AB1 3 ILE B 222 LEU B 231 -1 O THR B 230 N THR B 184 SHEET 3 AB1 3 VAL B 234 THR B 240 -1 O VAL B 234 N LEU B 231 LINK C DSE C 1 N DAL C 2 1555 1555 1.45 LINK N DSE C 1 C1 M12 C 101 1555 1555 1.45 LINK C DAL C 2 N GLY C 3 1555 1555 1.45 LINK C GLY C 3 N 5PG C 4 1555 1555 1.43 LINK C 5PG C 4 N ALA C 5 1555 1555 1.47 LINK CD2 5PG C 4 CE2 TYR C 6 1555 1555 1.52 LINK C DSE D 1 N DAL D 2 1555 1555 1.45 LINK N DSE D 1 C1 M12 D 101 1555 1555 1.46 LINK C DAL D 2 N GLY D 3 1555 1555 1.44 LINK C GLY D 3 N 5PG D 4 1555 1555 1.43 LINK C 5PG D 4 N ALA D 5 1555 1555 1.46 LINK CD2 5PG D 4 CE2 TYR D 6 1555 1555 1.51 CISPEP 1 MET A 93 PRO A 94 0 2.36 CISPEP 2 MET B 93 PRO B 94 0 1.22 CRYST1 71.800 71.800 263.310 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013928 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013928 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003798 0.00000 CONECT 3481 3482 3486 3583 CONECT 3482 3481 3483 3485 CONECT 3483 3482 3484 3488 CONECT 3484 3483 CONECT 3485 3482 3487 CONECT 3486 3481 CONECT 3487 3485 CONECT 3488 3483 3489 CONECT 3489 3488 3490 3491 CONECT 3490 3489 CONECT 3491 3489 3492 3493 CONECT 3492 3491 CONECT 3493 3491 CONECT 3495 3497 CONECT 3497 3495 3498 3501 CONECT 3498 3497 3499 3502 CONECT 3499 3498 3500 3509 CONECT 3500 3499 CONECT 3501 3497 CONECT 3502 3498 3503 3504 CONECT 3503 3502 3505 CONECT 3504 3502 3506 CONECT 3505 3503 3507 CONECT 3506 3504 3507 3523 CONECT 3507 3505 3506 3508 CONECT 3508 3507 CONECT 3509 3499 CONECT 3523 3506 CONECT 3528 3529 3533 3595 CONECT 3529 3528 3530 3532 CONECT 3530 3529 3531 3535 CONECT 3531 3530 CONECT 3532 3529 3534 CONECT 3533 3528 CONECT 3534 3532 CONECT 3535 3530 3536 CONECT 3536 3535 3537 3538 CONECT 3537 3536 CONECT 3538 3536 3539 3540 CONECT 3539 3538 CONECT 3540 3538 CONECT 3542 3544 CONECT 3544 3542 3545 3548 CONECT 3545 3544 3546 3549 CONECT 3546 3545 3547 3556 CONECT 3547 3546 CONECT 3548 3544 CONECT 3549 3545 3550 3551 CONECT 3550 3549 3552 CONECT 3551 3549 3553 CONECT 3552 3550 3554 CONECT 3553 3551 3554 3570 CONECT 3554 3552 3553 3555 CONECT 3555 3554 CONECT 3556 3546 CONECT 3570 3553 CONECT 3575 3576 3577 CONECT 3576 3575 CONECT 3577 3575 3578 CONECT 3578 3577 CONECT 3579 3580 3581 CONECT 3580 3579 CONECT 3581 3579 3582 CONECT 3582 3581 CONECT 3583 3481 3584 3585 CONECT 3584 3583 CONECT 3585 3583 3586 CONECT 3586 3585 3587 CONECT 3587 3586 3588 CONECT 3588 3587 3589 CONECT 3589 3588 3590 CONECT 3590 3589 3591 CONECT 3591 3590 3592 CONECT 3592 3591 3593 CONECT 3593 3592 3594 CONECT 3594 3593 CONECT 3595 3528 3596 3597 CONECT 3596 3595 CONECT 3597 3595 3598 CONECT 3598 3597 3599 CONECT 3599 3598 3600 CONECT 3600 3599 3601 CONECT 3601 3600 3602 CONECT 3602 3601 3603 CONECT 3603 3602 3604 CONECT 3604 3603 3605 CONECT 3605 3604 3606 CONECT 3606 3605 MASTER 500 0 10 6 46 0 0 6 3726 4 88 42 END